Prognostic and immunological profiling of SEC61G in cervical squamous cell carcinoma and adenocarcinoma
This study provides the first comprehensive analysis of the role of SEC61G in pan-cancer and cervical squamous cell carcinoma and adenocarcinoma. Our findings suggest that SEC61G can serve as a diagnostic biomarker and prognostic indicator for cervical cancers.
Authors
- Li Song (ORCID: https://orcid.org/0000-0002-5023-9111)
- Shupeng Liu (ORCID: https://orcid.org/0009-0003-6345-1140)
- Jingzhi Zhang (ORCID: https://orcid.org/0000-0001-5672-8349)
- Songtao Han (ORCID: https://orcid.org/0000-0003-2575-7571)
- Ye Yang (ORCID: https://orcid.org/0000-0001-6338-4206)
Institutions
- Xinjiang Medical University (CN)
- Changji University (CN)
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1007/s12672-025-03923-z
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00